Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$10.25 - $22.43 $3,915 - $8,568
382 New
382 $8,000
Q3 2021

Nov 05, 2021

SELL
$23.84 - $32.03 $7,509 - $10,089
-315 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$29.06 - $38.83 $9,153 - $12,231
315 New
315 $9,000
Q1 2021

May 24, 2021

SELL
$39.04 - $64.6 $12,297 - $20,349
-315 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$37.44 - $64.63 $11,793 - $20,358
315 New
315 $14,000
Q2 2020

Aug 10, 2020

SELL
$17.62 - $58.71 $5,286 - $17,613
-300 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$12.26 - $41.14 $3,678 - $12,342
300 New
300 $7,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $66.7M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.